Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New phase II study investigates Tarceva in poor performance NSCLC patients

March 23, 2004

Chiron discontinues development of tezacitabine

March 23, 2004

Pharmacia describes new protein kinase inhibitors, their preparation and use

March 22, 2004

GTx enters collaboration and license agreement with Ortho Biotech for andarine

March 22, 2004

Greater prevention of breast cancer recurrence with exemestane

March 22, 2004

Recombinant immunotoxins against breast cancer, osteosarcoma and neuroblastoma

March 22, 2004

Corgenix Medical and Genesis Bioventures sign merger agreement

March 19, 2004

Maxim reacquires rights to MX-2105 series

March 19, 2004

Novel antiangiogenic tyrosine kinase inhibitor claimed by Boehringer Ingelheim

March 19, 2004

Launch of new Salagen dosage

March 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...